Brian A Crowe Selected Research

OspA protein

11/2014	A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.
8/2013	Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.
1/2013	Evaluation of OspA vaccination-induced serological correlates of protection against Lyme borreliosis in a mouse model.
2/2011	A new approach to a Lyme disease vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian A Crowe Research Topics

Disease

7	Human Influenza (Influenza) 01/2014 - 08/2007
4	Infections 01/2013 - 02/2010
3	Lyme Disease (Disease, Lyme) 11/2014 - 01/2013
3	Vaccinia 01/2011 - 08/2010
2	Influenza in Birds (Avian Flu) 05/2009 - 08/2007
1	Chronic Disease (Chronic Diseases) 06/2014
1	Pain (Aches) 08/2013
1	Headache (Headaches) 08/2013
1	Yellow Fever 01/2011

Drug/Important Bio-Agent (IBA)

10	VaccinesIBA 06/2014 - 08/2007
4	OspA proteinIBA 11/2014 - 02/2011
3	Influenza Vaccines (Influenza Vaccine)FDA Link 06/2014 - 08/2007
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 01/2011
2	Hemagglutinins (Hemagglutinin)IBA 01/2011 - 08/2010
1	Neutralizing AntibodiesIBA 06/2014
1	cyclo(Arg-Pro) (CI 4)IBA 08/2013
1	EpitopesIBA 01/2013
1	Immunoglobulin G (IgG)IBA 01/2013
1	AntigensIBA 02/2011
1	Neuraminidase (Sialidase)IBA 08/2010
1	Inactivated VaccinesIBA 08/2010
1	AntibodiesIBA 02/2010